Literature DB >> 22187001

Movement disorders in 2011: Translating new research findings into clinical practice.

Christine Klein1, Dimitri Krainc.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22187001     DOI: 10.1038/nrneurol.2011.212

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

Review 1.  Towards unveiling the genetics of neurodegenerative diseases.

Authors:  Christina M Lill; Lars Bertram
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

2.  Frequency of the D620N mutation in VPS35 in Parkinson disease.

Authors:  Kishore R Kumar; Anne Weissbach; Marcus Heldmann; Meike Kasten; Sinem Tunc; Carolyn M Sue; Marina Svetel; Vladimir S Kostić; Juan Segura-Aguilar; Alfredo Ramirez; David K Simon; Peter Vieregge; Thomas F Münte; Johann Hagenah; Christine Klein; Katja Lohmann
Journal:  Arch Neurol       Date:  2012-10

3.  Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.

Authors:  Joseph R Mazzulli; You-Hai Xu; Ying Sun; Adam L Knight; Pamela J McLean; Guy A Caldwell; Ellen Sidransky; Gregory A Grabowski; Dimitri Krainc
Journal:  Cell       Date:  2011-06-23       Impact factor: 41.582

4.  A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.

Authors:  Alexander Zimprich; Anna Benet-Pagès; Walter Struhal; Elisabeth Graf; Sebastian H Eck; Marc N Offman; Dietrich Haubenberger; Sabine Spielberger; Eva C Schulte; Peter Lichtner; Shaila C Rossle; Norman Klopp; Elisabeth Wolf; Klaus Seppi; Walter Pirker; Stefan Presslauer; Brit Mollenhauer; Regina Katzenschlager; Thomas Foki; Christoph Hotzy; Eva Reinthaler; Ashot Harutyunyan; Robert Kralovics; Annette Peters; Fritz Zimprich; Thomas Brücke; Werner Poewe; Eduard Auff; Claudia Trenkwalder; Burkhard Rost; Gerhard Ransmayr; Juliane Winkelmann; Thomas Meitinger; Tim M Strom
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

5.  AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

Authors:  Peter A LeWitt; Ali R Rezai; Maureen A Leehey; Steven G Ojemann; Alice W Flaherty; Emad N Eskandar; Sandra K Kostyk; Karen Thomas; Atom Sarkar; Mustafa S Siddiqui; Stephen B Tatter; Jason M Schwalb; Kathleen L Poston; Jaimie M Henderson; Roger M Kurlan; Irene H Richard; Lori Van Meter; Christine V Sapan; Matthew J During; Michael G Kaplitt; Andrew Feigin
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

6.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Authors:  E R Dorsey; R Constantinescu; J P Thompson; K M Biglan; R G Holloway; K Kieburtz; F J Marshall; B M Ravina; G Schifitto; A Siderowf; C M Tanner
Journal:  Neurology       Date:  2006-11-02       Impact factor: 9.910

Review 7.  Progress toward the clinical application of patient-specific pluripotent stem cells.

Authors:  Evangelos Kiskinis; Kevin Eggan
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

8.  VPS35 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Christian Wider; Owen A Ross; Justus C Dachsel; Jennifer M Kachergus; Sarah J Lincoln; Alexandra I Soto-Ortolaza; Stephanie A Cobb; Greggory J Wilhoite; Justin A Bacon; Bahareh Behrouz; Heather L Melrose; Emna Hentati; Andreas Puschmann; Daniel M Evans; Elizabeth Conibear; Wyeth W Wasserman; Jan O Aasly; Pierre R Burkhard; Ruth Djaldetti; Joseph Ghika; Faycal Hentati; Anna Krygowska-Wajs; Tim Lynch; Eldad Melamed; Alex Rajput; Ali H Rajput; Alessandra Solida; Ruey-Meei Wu; Ryan J Uitti; Zbigniew K Wszolek; François Vingerhoets; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

9.  α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

Authors:  Kiran Yanamandra; Marina A Gruden; Vida Casaite; Rolandas Meskys; Lars Forsgren; Ludmilla A Morozova-Roche
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

  9 in total
  1 in total

1.  Parkin Modulates Endosomal Organization and Function of the Endo-Lysosomal Pathway.

Authors:  Pingping Song; Katarina Trajkovic; Taiji Tsunemi; Dimitri Krainc
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.